Table 2.

Stratified log-rank analysis for second-generation antipsychotic long-acting injectable study endpoints.

	n	Observed endpoints	Expected endpoints
Aripiprazole	16	5	8.79
Olanzapine	2	2	0.73
Paliperidone	49	18	25.453
Risperidone	90	64	54.025

Observed and expected number of patients reaching study endpoints in patients on each long-acting injectable are shown.